sulmazole has been researched along with Aortic Coarctation in 1 studies
sulmazole: structure given in first source
sulmazole : An imidazopyridine that is 1H-imidazo[4,5-b]pyridine which is substituted at position 2 by a 2-methoxy-4-(methylsulfinyl)phenyl group. An A1 adenosine receptor antagonist, it was formerly used as a cardiotonic agent.
Aortic Coarctation: A birth defect characterized by the narrowing of the AORTA that can be of varying degree and at any point from the transverse arch to the iliac bifurcation. Aortic coarctation causes arterial HYPERTENSION before the point of narrowing and arterial HYPOTENSION beyond the narrowed portion.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bambach, T | 1 |
| Nechwatal, W | 1 |
| Sigel, H | 1 |
| Stauch, M | 1 |
1 trial available for sulmazole and Aortic Coarctation
| Article | Year |
|---|---|
Assessment of left ventricular function from the mitral valve echocardiogram following positive and negative inotropic interventions.
Topics: Adolescent; Adult; Aged; Aortic Coarctation; Cardiac Pacing, Artificial; Coronary Angiography; Coron | 1983 |